Bronchial Asthma

Bronchial Asthma is short for asthma, and domestic works are also called asthma. It is a chronic inflammatory disease of the airway involving a variety of cells (such as mast cells, eosinophils, T lymphocytes, neutrophils, airway epithelial cells, etc.) and cell components. This chronic inflammation is associated with airway hyperresponsiveness, and usually has a wide range of reversible airflow limitations, and causes recurrent wheezing, shortness of breath, chest tightness, cough and other symptoms, often at night and / or early morning, Aggravated, most patients can resolve on their own or after treatment. If bronchial asthma is not diagnosed and treated in time, irreversible narrowing of the airway and remodeling of the airway may occur with the prolongation of the disease course. When asthma is controlled, asthma attacks rarely occur in most patients, and severe asthma attacks are less common. Data from the global burden of asthma suggest that, although the cost of controlling asthma seems to be high from a patient and social perspective, incorrect treatment can lead to recurrent asthma and the cost of treatment will be higher. Therefore, reasonable prevention and control is essential. To this end, asthma experts from all over the world have drafted and continuously updated the Global Initiative For Asthma (GINA). GINA has become an important guide for the prevention and treatment of asthma.

The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.